Re: Peter K.-F. Chiu, Chi-Fai Ng, Axel Semjonow, et al. A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings. Eur Urol 2019;75:558-61

Eur Urol. 2019 Jun;75(6):e158-e159. doi: 10.1016/j.eururo.2018.12.041. Epub 2019 Jan 5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Male
  • Prevalence
  • Prostate-Specific Antigen
  • Prostatic Neoplasms*
  • Reference Values

Substances

  • Prostate-Specific Antigen